<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000468787"><TermName>PF-00299804</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called protein tyrosine kinase inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>PF-00299804</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Pertenece al tipo de medicamentos llamados inhibidores de la tirosina cinasa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-10-14</DateFirstPublished></GlossaryTerm>
